2586 studies found for:    "Lymphoma, Non-Hodgkin"
Show Display Options
RSS Create an RSS feed from your search for:
"Lymphoma, Non-Hodgkin"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients
Conditions: Lymphoma, Non-Hodgkin;   Hodgkin Disease;   Multiple Myeloma
Interventions: Drug: TXA127;   Drug: Placebo
2 Recruiting Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Interventions: Procedure: Stem cell infusion;   Procedure: TLI;   Drug: Anti-thymocyte globulin;   Drug: Solumedrol;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
3 Recruiting ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas
Conditions: Lymphoma, Large-Cell, Anaplastic;   Lymphoma, Non-Hodgkin;   Lymphoma, T-Cell
Interventions: Drug: brentuximab vedotin;   Drug: doxorubicin;   Drug: prednisone;   Drug: vincristine;   Drug: cyclophosphamide
4 Approved for marketing A Treatment-Option Study of Brentuximab Vedotin in Patients With Progression of Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma
Conditions: Disease, Hodgkin;   Lymphoma, Large-Cell, Anaplastic;   Lymphoma, Non-Hodgkin
Intervention: Drug: brentuximab vedotin
5 Completed Study of SGN-40 in Patients With Relapsed Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Non-Hodgkin
Intervention: Drug: SGN-40
6 Active, not recruiting
Has Results
A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma
Conditions: Lymphoma, Large-Cell, Anaplastic;   Lymphoma, Non-Hodgkin
Intervention: Drug: brentuximab vedotin
7 Terminated
Has Results
T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE
Conditions: Leukemia;   Cancer;   Lymphoma;   Lymphoma, Hodgkin;   Lymphoma, Non-Hodgkin
Interventions: Drug: Ara C;   Drug: Mesna;   Drug: Cyclophosphamide;   Radiation: TBI-Total Body Irradiation
8 Completed Study of Recombinant Interleukin 21 in Combination With Rituxan for Non-Hodgkin's Lymphoma
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: recombinant human interleukin 21 and rituximab
9 Completed Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients
Conditions: Neoplasms by Site;   Lymphoma, Non-hodgkin;   Hodgkin Disease;   Multiple Myeloma;   Leukemia, Lymphocytic, Chronic
Intervention: Drug: PCI-24781
10 Terminated Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas.
Condition: Lymphoma, Non-Hodgkin
Intervention: Drug: Zevalin
11 Completed A Study of Mitoguazone Dihydrochloride in Patients With AIDS-Related Non-Hodgkin's Lymphoma
Conditions: Lymphoma, Non-Hodgkin;   HIV Infections
Intervention: Drug: Mitoguazone
12 Terminated A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL
Conditions: Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Non-Hodgkin
Interventions: Drug: SGN-40;   Drug: placebo;   Drug: rituximab;   Drug: etoposide;   Drug: carboplatin;   Drug: ifosfamide
13 Completed A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
Conditions: Carcinoma, Renal Cell;   Lymphoma, Non-Hodgkin
Intervention: Drug: SGN-75
14 Recruiting Hematopoietic Stem Cell Transplantation (HSCT) Using CD34 Selected Mismatched Related Donor and One Umbilical Cord Unit
Conditions: Leukemia, Lymphocytic, Acute;   Leukemia, Lymphocytic, Chronic;   Leukemia, Myelocytic, Acute;   Leukemia, Myeloid, Chronic;   Lymphoma, Non-Hodgkin;   Lymphoma, Hodgkins
Intervention: Other: Haploidentical/cord transplant
15 Completed Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic Malignancies
Conditions: Lymphoma, Non-Hodgkin;   Disease, Hodgkin;   Lymphoma, Large-Cell, Anaplastic
Intervention: Drug: SGN-35
16 Active, not recruiting A Study of Brentuximab Vedotin in Relapsed or Refractory Non-Hodgkin Lymphoma
Conditions: Lymphoma, B-Cell;   Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Non-Hodgkin;   Lymphoma, T-Cell
Interventions: Drug: brentuximab vedotin;   Drug: rituximab
17 Completed Trial to Define the Safety and Tolerability of SGN-40, Rituximab, and Gemcitabine in Patients With DLBCL
Conditions: Lymphoma, Large B-Cell, Diffuse;   Lymphoma, Non-Hodgkin
Interventions: Drug: SGN-40;   Drug: rituximab;   Drug: gemcitabine
18 Completed Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease
Conditions: Leukemia;   Lymphoma, Non-Hodgkin;   Hodgkin Disease;   Myelodysplastic Syndromes;   Multiple Myeloma
Interventions: Genetic: CD34-TK75 transduced donor lymphocytes;   Radiation: Sub Study - 18 FHBG PET/CT Scans
19 Active, not recruiting Randomized Double Cord Blood Transplant Study
Conditions: Leukemia, Lymphocytic, Acute;   Leukemia, Myelocytic, Acute;   Leukemia, Myeloid, Chronic;   Lymphoma, Non-Hodgkin
Interventions: Procedure: Expanded allogeneic cord blood (CB);   Procedure: One Unmanipulated and One Expanded Cord Blood Unit;   Drug: Rituxan;   Drug: Melphalan;   Drug: Thiotepa;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mesna
20 Completed Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
Conditions: Carcinomas;   Disease, Hodgkin;   Lymphoma, Large-Cell, Anaplastic;   Lymphoma, Non-Hodgkin;   Neoplasms
Interventions: Drug: brentuximab vedotin;   Drug: rifampin;   Drug: midazolam;   Drug: ketoconazole

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years